SavedAdd your journal

Journals / Turkish Journal of Gastroenterology / 2008 / Cilt: 19 - Sayı: 2

İmatinib mesylate’la tedavi önce ve sonrasında kistik karaciğer metastazının görüntüleme bulguları

Imaging characteristics of liver metastasis from gastrointestinal stromal tumor before and after imatinib mesylate treatment

Şerife ULUSAN
ZAFER KOÇ
FAZİLET KAYASELÇUK
Pages
129–132
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our objective was to show the unusual imaging characteristics of cystic liver metastases from a malignant gastrointestinal stromal tumor before and after treatment with imatinib mesylate.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Our objective was to show the unusual imaging characteristics of cystic liver metastases from a malignant gastrointestinal stromal tumor before and after treatment with imatinib mesylate.
📊
Key Findings & Data:Our objective was to show the unusual imaging characteristics of cystic liver metastases from a malignant gastrointestinal stromal tumor before and after treatment with imatinib mesylate.
💡
Conclusion & Impact:Our objective was to show the unusual imaging characteristics of cystic liver metastases from a malignant gastrointestinal stromal tumor before and after treatment with imatinib mesylate.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Piperazinler · Gastrointestinal stromal tümörler · Kolon

Abstract

Our objective was to show the unusual imaging characteristics of cystic liver metastases from a malignant gastrointestinal stromal tumor before and after treatment with imatinib mesylate.

Özet

Bu yazımızda malign gastrointestinal stromal tümörün kistik karaciğer metastazlarının imatinib mesylate’la tedavi önce ve sonrasında atipik radyolojik bulgularının gösterilmesi amaçlanmıştır.

🔖

Cite This Article

ULUSAN, Ş., KOÇ, Z., KAYASELÇUK, F. (2008). İmatinib mesylate’la tedavi önce ve sonrasında kistik karaciğer metastazının görüntüleme bulguları. Turkish Journal of Gastroenterology, Cilt: 19 - Sayı: 2, 129–132. https://ajindex.com/articles/409902

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 2002; 33: 669-76
  2. Miettinen M, El-Rifai W, H L Sobin L, Lasota J. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol 2002; 33: 478-83
  3. Sandrasegaran K, Rajesh A, Rushing DA, et al. Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol 2005; 15: 1407-14
  4. Kim HC, Lee JM, Kim KW, et al. Gastrointestinal stromal tumors of the stomach: CT findings and prediction of malignancy. AJR 2004; 183: 893-8
  5. Burkill GJ, Badran M, Al-Muderis O, et al. Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology 2003; 226: 527-32
  6. Kim HC, Lee JM, Choi SH, et al. Cystic changes in intraabdominal extrahepatic metastases from gastrointestinal stromal tumors treated with imatinib. Korean J Radiol 2004; 5: 157-63
  7. Chen MY, Bechtold RE, Savage PD. Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GISTs) treated with Gleevec (imatinib mesylate). AJR 2002; 179: 1059-62
  8. Vanel D, Albiter M, Shapeero L, et al. Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients. Eur J Radiol 2005; 54: 118-23.